July 22, 2020 International Waldenstrom Macroglobulinemia Foundation
Jeffrey V. Matous MD – Colorado Blood Cancer Institute, and the University of Colorado. July 2020 IWMF Global Educational Webinar Series
The International Waldenstrom’s Macroglobulinemia Foundation invites you to join us for the first installment in our 2020 IWMF Global Educational Webinar series. Through this free interactive webinar series, you will learn from the best and brightest minds in WM research, and participate in a live Q&A session from the comfort of your own home. This webinar will benefit newly diagnosed patients and veteran WMers alike with a refresher course on the basics of WM that includes diagnosis, symptoms, and treatment guidelines.
The IWMF appreciates the efforts of Dr. Jeffrey V. Matous for his time and energy to make this webinar possible. The IWMF is able to offer this incredible opportunity free of charge, thanks to the generosity of WM community members like you.
Jeffrey Matous, MD -Colorado Blood Cancer Institute, 2019 Ed Forum
Teaches the newly diagnosed patient to understand their blood tests, as well as other tests for WM and provides a refresher course for veteran WM’ers
Peter DeNardis, IWMF Trustee & WM Warrior, 2019 Ed Forum
Provides everything you wanted to ask about living with WM upon diagnosis but were too numb to ask!
Jeffrey Matous, MD -Colorado Blood Cancer Institute, 2019 Ed Forum
Prepares the newly diagnosed patient to get the most out of the other videos from this Educational Forum and provides a refresher course for veteran WM’ers
Stephen Ansell MD, PhD – Mayo Clinic Rochester, 2018 Ed Forum
Provides the IWMF-LLS Strategic Research Roadmap and addresses the uniqueness of WM, its genomics, epigenomics, MYD88 L265P and CXCR4 mutations, and treatment options
Morie Gertz, MD, FACP – Mayo Clinic Rochester, 2017 Ed Forum
Raises questions and answers about WM, such as, “Are my kids going to get this? How long will I live? What can I do to live longer?” just to name a few
Stephen Ansell, MD, PhD – Mayo Clinic Rochester, 2017 Ed Forum
Provides the IWMF-LLS Strategic Research Roadmap and addresses the uniqueness of WM, its genomics, epigenomics, MYD88 L265P and CXCR4 mutations, treatment options, and survival
Jeffrey Matous, MD – Colorado Blood Cancer Institute, 2017 Ed Forum
Prepares the newly diagnosed to get the most out of the other videos and provides a refresher course for veteran WM’ers
Morton Coleman, MD – Weill Cornell Medical College, 2016 Ed Forum
Discusses the frequency of various lymphoma subtypes in adults, with emphasis on WM and cancer drug development and reviews the signaling pathways in WM, drugs that inhibit WM cell survival and discusses the challenges of combining drugs and limiting side effects
Jeffrey Matous, MD, & Megan Andersen, NP-C – Colorado Blood Cancer Institute, 2016 Ed Forum
Prepares the newly diagnosed to get the most out of the other videos and provides a refresher course for veteran WM’ers
Jeffrey Matous, MD- Colorado Blood Cancer Institute, 2015 Ed Forum
The prognosis varies from person to person, depending upon a variety of factors, including age at diagnosis and severity of symptoms. Fortunately recent advances in research (much of which has been funded by the IWMF) have extended this diagnosis significantly.
Dr. Mary Lou McMaster of NIH discusses WM biology and treatments and focuses on the topic of familial WM in her presentation to the Northern Virginia IWMF Support Group in October 2014. This video is approximately 1 hour and 30 minutes in length. Anyone wishing to view it in segments can use the following as a guide: 0 to 33 minutes – general discussion of WM, IgM, and B-cell biology; 33 minutes to 1 hour – review of the principles of WM progression and treatment; 1 hour to end – familial WM and susceptibility.
Morie Gertz, MD – Mayo Clinic, Rochester, 2014 Ed Forum
Raises questions and answers about WM, such as, “Are my kids going to get this? How long will I live? What can I do to live longer?” just to name a few.
